These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8226149)

  • 1. The use of iodine-125 seeds as a substitute for iridium-192 seeds in temporary interstitial breast implants.
    Vicini F; White J; Gustafson G; Matter RC; Clarke DH; Edmundson G; Martinez A
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):561-6. PubMed ID: 8226149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome with interstitial brachytherapy in the management of patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Horwitz EM; Lacerna MD; Dmuchowski CF; Brown DM; White J; Chen PY; Edmundson GK; Gustafson GS; Clarke DH; Gustafson GS; Matter RC; Martinez AA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):845-52. PubMed ID: 9128961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of boost technique on outcome in early-stage breast cancer patients treated with breast-conserving therapy.
    Frazier RC; Kestin LL; Kini V; Martinez AA; Chen PY; Baglan KL; Vicini FA
    Am J Clin Oncol; 2001 Feb; 24(1):26-32. PubMed ID: 11232945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases.
    Deore SM; Sarin R; Dinshaw KA; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):601-6. PubMed ID: 8330988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial.
    Vicini FA; Chen PY; Fraile M; Gustafson GS; Edmundson GK; Jaffray DA; Benitez P; Pettinga J; Madrazo B; Ingold JA; Goldstein NS; Matter RC; Martinez AA
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):301-10. PubMed ID: 9226316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical advantages of I-125 seeds as a substitute for Ir-192 seeds in temporary plastic tube implants.
    Clarke DH; Edmundson GK; Martinez A; Matter RC; Vicini F; Sebastian E
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):859-63. PubMed ID: 2777677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
    Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.
    Lawenda BD; Taghian AG; Kachnic LA; Hamdi H; Smith BL; Gadd MA; Mauceri T; Powell SN
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):671-80. PubMed ID: 12788172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy.
    Touboul E; Belkacemi Y; Lefranc JP; Uzan S; Ozsahin M; Korbas D; Buffat L; Balosso J; Pene F; Blondon J
    Radiother Oncol; 1995 Feb; 34(2):105-13. PubMed ID: 7597208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial.
    Ott OJ; Pötter R; Hammer J; Hildebrandt G; Lotter M; Resch A; Pöhls U; Beckmann MW; Sauer R; Strnad V
    Strahlenther Onkol; 2004 Oct; 180(10):642-9. PubMed ID: 15480513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utilization of I-125 seeds as a substitute for Ir-192 seeds in temporary interstitial implants: an overview and a description of the William Beaumont Hospital technique.
    Clarke DH; Edmundson GK; Martinez A; Matter RC; Warmelink C
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):1027-33. PubMed ID: 3182311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
    Lin L; Patel RR; Thomadsen BR; Henderson DL
    Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Partial breast irradiation for early breast cancer with favorable prognostic factors: 3-year results of the German-Austrian phase II-trial].
    Ott OJ; Pötter R; Hildebrandt G; Hammer J; Lotter M; Beckmann MW; Sauer R; Strnad V
    Rofo; 2005 Jul; 177(7):962-7. PubMed ID: 15973598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial.
    Fourquet A; Campana F; Mosseri V; Cetingoz R; Luciani S; Labib A; Asselain B; Vilcoq JR
    Radiother Oncol; 1995 Feb; 34(2):114-20. PubMed ID: 7597209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant.
    Mazeron JJ; Simon JM; Crook J; Calitchi E; Otmezguine Y; Le Bourgeois JP; Pierquin B
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1173-7. PubMed ID: 1938515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative implantation of iridium-192 as the boost technique for stage I and II breast cancer: results of a 10-year study of 655 patients.
    Mansfield CM; Komarnicky LT; Schwartz GF; Rosenberg AL; Krishnan L; Jewell WR; Rosato FE; Moses ML; Barbot D; Cohn HE
    Radiology; 1994 Jul; 192(1):33-6. PubMed ID: 8208960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy.
    Wazer DE; Kramer B; Schmid C; Ruthazer R; Ulin K; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):381-93. PubMed ID: 9308942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.